Remove Biosimilars Remove Magazine Remove Pharmaceutical Manufacturing
article thumbnail

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? Alvotech has moved one step closer to entering the Eylea (aflibercept 2 mg) biosimilar market, after a European Medicines Agency (EMA) panel recommended approval of its copycat biologic. CucuMberStudio via Shutterstock.

article thumbnail

Pharmaceutical Technology Excellence Awards 2025: i3 Membrane

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? This flexibility is particularly beneficial for pharmaceutical manufacturers looking to upgrade their research and discovery processes without overhauling their entire systems. “Great thanks to Pharmaceutical Technology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Navamedic signs agreement to acquire dne pharma

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”?

article thumbnail

Zambon gains Chinese regulatory authority approval for Fluimucil IV

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”?

article thumbnail

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”?